SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. W. Hsu, N. H. Dang, ALK1 as a Novel Therapeutic Target for CD30+ T-Anaplastic Large Cell Lymphoma, JNCI Journal of the National Cancer Institute, 2014, 106, 2, djt454

    CrossRef

  2. 2
    Kristen Ganjoo, Fangxin Hong, Sandra J. Horning, Randy D. Gascoyne, Yasodha Natkunam, Lode J. Swinnen, Thomas M. Habermann, Brad S. Kahl, Ranjana H. Advani, Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404), Leukemia & Lymphoma, 2014, 55, 4, 768

    CrossRef

  3. 3
    Nishitha M. Reddy, Andrew M. Evens, Chemotherapeutic Advancements in Peripheral T-Cell Lymphoma, Seminars in Hematology, 2014, 51, 1, 17

    CrossRef

  4. 4
    Zhiyuan Zhou, Xiang Li, Changying Chen, Xin Li, Lei Zhang, Ling Li, Xinhua Wang, Wang Ma, Xiaorui Fu, Jingjing Wu, Zhenchang Sun, Xudong Zhang, Zhaoming Li, Jiaqin Yan, Yu Chang, Lisha Lu, Beibei Qin, Xiaoli Li, Jianguo Wen, Mingzhi Zhang, Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients, Annals of Hematology, 2014, 93, 11, 1889

    CrossRef

  5. 5
    Andrew M. Intlekofer, Anas Younes, From empiric to mechanism-based therapy for peripheral T cell lymphoma, International Journal of Hematology, 2014, 99, 3, 249

    CrossRef

  6. 6
    A. J. Moskowitz, M. A. Lunning, S. M. Horwitz, How I treat the peripheral T-cell lymphomas, Blood, 2014, 123, 17, 2636

    CrossRef

  7. 7
    S. M. Horwitz, R. H. Advani, N. L. Bartlett, E. D. Jacobsen, J. P. Sharman, O. A. O'Connor, T. Siddiqi, D. A. Kennedy, Y. Oki, Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin, Blood, 2014, 123, 20, 3095

    CrossRef

  8. 8
    Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, Stefano A Pileri, Pier Luigi Zinzani, Past, present and future treatment strategies in peripheral T-cell lymphomas, International Journal of Hematologic Oncology, 2014, 3, 4, 299

    CrossRef

  9. 9
    Maria Gkotzamanidou, Christos A. Papadimitriou, Peripheral T-cell lymphoma: The role of hematopoietic stem cell transplantation, Critical Reviews in Oncology/Hematology, 2014, 89, 2, 248

    CrossRef

  10. 10
    Kevin R. Kelly, Thomas C. Shea, André Goy, Jesus G. Berdeja, Craig B. Reeder, Kevin T. McDonagh, Xiaofei Zhou, Hadi Danaee, Hua Liu, Jeffrey A. Ecsedy, Huifeng Niu, Ely Benaim, Swaminathan Padmanabhan Iyer, Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia, Investigational New Drugs, 2014, 32, 3, 489

    CrossRef

  11. 11
    F. Ellin, J. Landstrom, M. Jerkeman, T. Relander, Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry, Blood, 2014, 124, 10, 1570

    CrossRef

  12. 12
    P. Corradini, M. Marchetti, G. Barosi, A. Billio, A. Gallamini, S. Pileri, N. Pimpinelli, G. Rossi, P. L. Zinzani, S. Tura, SIE-SIES-GITMO Guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias, Annals of Oncology, 2014, 25, 12, 2339

    CrossRef

  13. 13
    Roopesh Kansara, Kerry J. Savage, The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma, Leukemia & Lymphoma, 2014, 55, 4, 727

    CrossRef

  14. 14
    R Briski, A L Feldman, N G Bailey, M S Lim, K Ristow, T M Habermann, W R Macon, D J Inwards, J P Colgan, G S Nowakowski, M S Kaminski, T E Witzig, S M Ansell, R A Wilcox, The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas, Blood Cancer Journal, 2014, 4, 5, e214

    CrossRef

  15. 15
    Koppany Visnyei, Michael L. Grossbard, Ilan Shapira, Hepatosplenic γδ T-cell Lymphoma: An Overview, Clinical Lymphoma Myeloma and Leukemia, 2013, 13, 4, 360

    CrossRef

  16. 16
    Matthew A. Lunning, Steven Horwitz, Treatment of Peripheral T-cell Lymphoma: Are We Data Driven or Driving the Data?, Current Treatment Options in Oncology, 2013, 14, 2, 212

    CrossRef